Pharm 23: Clots and bleeds Flashcards

1
Q

How does aspirin thin the blood

A

Inhibits the synthesis of prostaglandins, thereby inhibiting the platelet granule release reaction and interfering with normal platelet aggregation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Aspirin inhibits (enzymes)

A

COX 1/2 non selective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In platelets, an increase in the concentration of intracellular ____ leads to a decrease in platelet _____

A

In platelets, an increase in the concentration of intracellular cAMP leads to a decrease in platelet aggregability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Inhibitors of platelet phosphodiesterase decrease platelet aggregability by inhibiting __________

A

Inhibitors of platelet phosphodiesterase decrease platelet aggregability by inhibiting cAMP degradation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Dipyridamole MOA

A

platelet phosphodiasterase inhibitor

decreased platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dipyridamole is administered with _________

Why?

A

Warfarin/aspirin

kinda weak

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dipyridamole side effect

A

Vasodilation leading to angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Drugs that inhibit ADP-dependent platelet activation

A

clopidogrel

ticlopidine

prasugrel

aka thienopyridines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ticlopidine indications

A

1) Secondary prevention of strokes when aspirin allergy
2)Post stent thrombosis prophylaxis (with aspirin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clopidogrel metabolism

A

Prodrug via P450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Clopidogrel indications

A

Secondary stroke prevention post MI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clopidogrel dosing considerations

A

Loading dose to achieve effect then maintanance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prasugrel use

A

Acute coronary syndromes during PCI

Cath lab drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Prasugrel major AE cosideration

A

Dont give to stroke bc of head bleed risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ticagrelor MOA

A

competitive P2Y12 ADP receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Tricagelor use

A

Acute coronary syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Tricagelor route

A

Oral with no hepatic activation needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Eptifibatide MOA

A

GPIIb–IIIa receptor antagonist

Platelet inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Abciximab MOA

A

Chimeric mouse–human monoclonal antibody directed against the human GPIIb–IIIa receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Tirofiban MOA

A

nonpeptide tyrosine analogue that reversibly antagonizes fibrinogen binding to the platelet GPIIb–IIIa receptor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Eptifibatide, tirofiban and abxcimab how to reveres

A

Abxicimab: give more platelets

Others: Wait

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Vorapaxar MOA

A

protease-activated receptor 1 (PAR-1) antagonist one of two major thrombin receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Warfarine MOA

A

Epoxide reductase inhibitor

vitamin K cant regenerate

24
Q

Warfarin dosing considerations

A

Delayed action takes many doses to reach effect

25
Warfarin kinetics
100% orally bioavailable, peak 1-4 hours, **99% albumin bound**
26
Warfarin drug drug interactions
Inhibitted by P450 enzyme activators Increased by P450 inhibittors or antibiotics (less vit K availability)
27
γ-carboxilated antiguaolant think
warfarin
28
Warfarin contraindications
Pregnancy (cross placenta and bleed fetus)
29
With warfarin monitor
PT/INR
30
Heparin MOA
Cofactor for antithrombin III -it serves as a catalytic surface to which both antithrombin III and the serine proteases bind -induces a conformational change in antithrombin III that makes the reactive site of this molecule more accessible to the attacking protease
31
LMW Heparin are more efficient in ___ and less efficient in _______.
More efficient: Catalyze factor Xa inactivation Less efficient: catalyze inactivation of thrombin
32
Unfractionated heparin
Less selective.. catalyzes both thrombin and factor Xa inactivation
33
Heparin structure
Pentasacchiride structure… super acidic
34
fondaparinux
Binds antithrombin III to indirectly inhibit Xa
35
Heparin effect monitored via
aPTT
36
LMW heparin names
Enoxaparin Dalteparin Tinzaparin
37
Rivaroxaban and apixaban MOA
Direcltly inhibit factor Xa by competitive inhibition do not require antithrobin III
38
Lepidurin MOA
Direct thrombin inhibitor
39
Heparin Induced Thrombocytopenia HIT MOA
Antibodies to hapten when heparin molecules bind to platelet. Platelets then removed by body
40
Desirudin use
DVT prophalaxis in hip replacement
41
HIT treatment
lepirudin
42
Bivalirudin MOA and use
Inhibits thrombin activity. Use in cath lab
43
Argatroban MOA and use
Thrombin inhibitor. Used for patients wtih HIT. Biliary excretion, use with bad kidneys No exosite activity
44
Dabigatran MOA and use
Oral direct thrombin inhibitor Use in non valve afib, and as warfarin substitute for mechanical valve pts
45
Dabigratan mechanics /monitoring
Prodrug… does not need to be monitored
46
Recombinant activated protein C (r-APC) MOA and use
Used in septic shock by cleaving factors Va and VIIIa
47
Streptokinase moa and use
1) Forms complex with plasminogen, exposing active site 2) Now active, plasminogen cleaves other plasminogens to plasmin STEMI and PE
48
t-PA MOA and use
Binds to fresh thrombus, causing fribinolysis. After binding, t-PA is conformationally changed and it can now activate plasminogen Use in stroke, STEMI, PE
49
Tenecteplase vs tPA
More resistant to plasminogen activator inhibitor 1 Longer half life Admin as single weight based bolus
50
Reteplase what to know
Re- use (2 boluses 30 min apart)
51
Protamine MOA and use
Chemical antagonist to heparin. used when too much heparin
52
Aprotinin MOA and use
Serine protease inhibitor: Plasmin, thrombin t-pa not really used bc anaphylaxis
53
54
55